Liver transplantation for hepatocellular carcinoma
- 1 April 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 22 (2) , 128-134
Abstract
This review discusses the current imaging modalities and criteria used to diagnose, and the role of liver transplantation as well as nonsurgical hepatic-directed therapies to treat hepatocellular carcinoma in the setting of chronic liver disease. There has been continual evolution of guidelines, policies, and algorithms for the imaging diagnosis of hepatocellular carcinoma, particularly the Liver Imaging Reporting and Data System. The use of liver-directed therapy as a bridge to transplant is now common practice. Recently, patients have waited 6 months from listing before being granted a Model for End-Stage Liver Disease exception score of 28, with an increase every 3 months to a maximum score of 34. This policy change was developed to reduce disparities in outcomes for patients undergoing liver transplantation. The use of liver transplantation to treat hepatocellular carcinoma within the Milan criteria has good outcomes with a 5-year disease-free survival rate comparable to patients transplanted without malignancy. The development of guidelines both for the radiologic diagnosis and staging of the primary tumor and guidelines for assessing response to treatment allows for a more unified approach to the management of patients. With the partnership of oncologists, hepatologists, radiologists, pathologists, and surgeons, the outcomes of liver transplantation as treatment for hepatocellular continue to improve.Keywords
This publication has 31 references indexed in Scilit:
- Cirrhotic liver: What's that nodule? The LI‐RADS approachJournal of Magnetic Resonance Imaging, 2015
- New OPTN/UNOS Policy for Liver Transplant Allocation: Standardization of Liver Imaging, Diagnosis, Classification, and Reporting of Hepatocellular CarcinomaRadiology, 2013
- Liver Transplantation for Hepatocellular Carcinoma: Long-Term Results Suggest Excellent OutcomesJournal of the American College of Surgeons, 2012
- Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendationsHepatology, 2012
- Clonality Analysis for Multicentric Origin and Intrahepatic Metastasis in Recurrent and Primary Hepatocellular CarcinomaJournal of Gastrointestinal Surgery, 2008
- Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasisThe Journal of Pathology, 2003
- Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact SurvivalHepatology, 2001
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996
- Is Liver Transplantation Justified for the Treatment of Hepatic Malignancies?Archives of Surgery, 1990
- Role of Liver Transplantation in Cancer TherapyAnnals of Surgery, 1985